Dr. Duncan Low

Dr. Duncan Low

Company: Claymore Biopharm LLC; Former Scientific Executive Director, Amgen

Job title: CEO


Duncan Low is a consultant providing technical services in raw materials management and risk management to both manufacturers and suppliers in the biopharmaceutical industry. He is an active member of several industry groups and scientific advisory boards, including the ASTM E55 Executive Committee developing consensus standards for Manufacture of Pharmaceutical Products, the ISPE Executive Committee for PAT, the Biophorum Operations Group, and has also been a significant contributor to the PDA Task Group for Single Use Systems and the USP’s Committee of Experts. He was co-chair of the 2009 IFPAC Conference. His broad experience includes his role as a Scientific Executive Director at Amgen (2003 – 2017), where he led the Raw Materials Global Network and Materials Science teams. Prior to joining Amgen he held VP positions at Millipore and Pharmacia Biotech. He has an M.A. in biochemistry from the University of Cambridge and a Ph.D. in microbiology from the University of Glasgow.


Think Tank Fireside Chat: How to Turn Continuous Bioprocessing into Reality? 11:00 am

What needs to happen? From interest to real commitment Downstream processing in biologics – challenges and opportunities The choice of equipment and platform – sticking with what you know vs choosing what is right for you? Adopting resin to platform or platform to resin? Quality and qualificationRead more

day: Online Agenda

Live Q&A – Ask Our Speakers Your Burning Questions 10:10 am

Read more

day: Online Agenda

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.